Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.78 - $1.02 $9,308 - $12,172
11,934 New
11,934 $10,000
Q1 2022

May 16, 2022

BUY
$0.82 - $1.1 $478 - $641
583 Added 3.02%
19,857 $18,000
Q4 2021

Feb 14, 2022

BUY
$0.96 - $1.63 $7,164 - $12,164
7,463 Added 63.19%
19,274 $20,000
Q3 2021

Nov 12, 2021

BUY
$1.45 - $1.84 $17,125 - $21,732
11,811 New
11,811 $18,000

About FSD Pharma Inc.


  • Ticker HUGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 38,218,100
  • Market Cap $5.73M
  • Description
  • FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...
More about HUGE
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.